• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带有右删失数据的生存函数的成对多重比较调整程序。

Pairwise Multiple Comparison Adjustment Procedure for Survival Functions with Right-Censored Data.

机构信息

Department of Biostatistics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

出版信息

Comput Math Methods Med. 2017;2017:9270450. doi: 10.1155/2017/9270450. Epub 2017 Oct 12.

DOI:10.1155/2017/9270450
PMID:29123552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5662801/
Abstract

The aim of this study is to propose a new pairwise multiple comparison adjustment procedure based on Genz's numerical computation of probabilities from a multivariate normal distribution. This method is applied to the results of two-sample log-rank and weighted log-rank statistics where the survival data contained right-censored observations. We conducted Monte Carlo simulation studies not only to evaluate the familywise error rate and power of the proposed procedure but also to compare the procedure with conventional methods. The proposed method is also applied to the data set consisting of 815 patients on a liver transplant waiting list from 1990 to 1999. It was found that the proposed method can control the type I error rate, and it yielded similar power as Tukey's and high power with respect to the other adjustment procedures. In addition to having a straightforward formula, it is easy to implement.

摘要

本研究旨在提出一种新的基于 Genz 数值计算的多元正态分布概率的成对多重比较调整程序。该方法应用于两样本对数秩和加权对数秩统计的结果,其中生存数据包含右删失观测值。我们进行了蒙特卡罗模拟研究,不仅评估了所提出方法的总体错误率和功效,还将其与传统方法进行了比较。该方法还应用于 1990 年至 1999 年期间 815 例肝移植等候名单患者的数据。结果发现,该方法可以控制第一类错误率,并且与 Tukey 方法相比,其功效相似,与其他调整方法相比,功效较高。除了具有直接的公式外,它还易于实现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43da/5662801/f30430e4135e/CMMM2017-9270450.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43da/5662801/f30430e4135e/CMMM2017-9270450.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43da/5662801/f30430e4135e/CMMM2017-9270450.001.jpg

相似文献

1
Pairwise Multiple Comparison Adjustment Procedure for Survival Functions with Right-Censored Data.带有右删失数据的生存函数的成对多重比较调整程序。
Comput Math Methods Med. 2017;2017:9270450. doi: 10.1155/2017/9270450. Epub 2017 Oct 12.
2
MELD-based allocation scheme for liver transplantation in Israel.以色列基于终末期肝病模型(MELD)的肝移植分配方案。
Isr Med Assoc J. 2006 Sep;8(9):651-2.
3
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.一种在共同的肝移植等待名单上为肝癌患者和非肝癌患者分配公平性的方法。
J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23.
4
Impact of Model for End-Stage Liver Disease in the occurrence of infectious events and survival in a cohort of liver transplant recipients.终末期肝病模型对肝移植受者队列中感染事件发生及生存情况的影响。
Transplant Proc. 2013 Jan-Feb;45(1):297-300. doi: 10.1016/j.transproceed.2012.02.046.
5
Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.以等待时间长为特征的肝移植等待名单上的死亡预测因素。
Transpl Int. 2005 May;18(5):572-6. doi: 10.1111/j.1432-2277.2005.00090.x.
6
Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.终末期肝病模型(MELD)在以色列是否有效?对肝移植等待名单死亡率的批判性分析。
Isr Med Assoc J. 2006 Sep;8(9):605-9.
7
Predicting patient survival after liver transplantation using evolutionary multi-objective artificial neural networks.利用进化多目标人工神经网络预测肝移植患者的生存情况。
Artif Intell Med. 2013 May;58(1):37-49. doi: 10.1016/j.artmed.2013.02.004. Epub 2013 Mar 13.
8
Deaths on the liver transplant waiting list: an analysis of competing risks.肝移植等待名单上的死亡情况:竞争风险分析
Hepatology. 2006 Feb;43(2):345-51. doi: 10.1002/hep.21025.
9
Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models.高风险与低风险患者的活体供肝移植:使用统计模型进行优化
Liver Transpl. 2006 Feb;12(2):231-9. doi: 10.1002/lt.20700.
10
Patient selection in liver transplant: when is it the right time to list?肝移植中的患者选择:何时是列入名单的合适时机?
Mayo Clin Proc. 2008 Feb;83(2):140-2. doi: 10.4065/83.2.140.

引用本文的文献

1
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall.蛋白质组学分析可改善 Sarculator 列线图对肢体和躯干壁软组织肉瘤的预后风险分层。
Cancer Med. 2024 Jul;13(14):e70026. doi: 10.1002/cam4.70026.
2
The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在预测接受姑息治疗的晚期肝细胞癌非洲黑人患者院内死亡率中的基线预后价值:一项比较队列研究
Hepat Med. 2021 Dec 8;13:123-134. doi: 10.2147/HMER.S333980. eCollection 2021.
3

本文引用的文献

1
Deaths on the liver transplant waiting list: an analysis of competing risks.肝移植等待名单上的死亡情况:竞争风险分析
Hepatology. 2006 Feb;43(2):345-51. doi: 10.1002/hep.21025.
2
Pairwise multiple comparison adjustment in survival analysis.
Stat Med. 2005 Aug 30;24(16):2509-23. doi: 10.1002/sim.2125.
3
A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.一种用于比较任意单删失样本的广义威尔科克森检验。
Biometrika. 1965 Jun;52:203-23.
Prognostic value of nocturnal blood pressure dipping on cardiovascular outcomes in Chinese patients with hypertension in primary care.在基层医疗中,中国高血压患者的夜间血压下降对心血管结局的预测价值。
J Clin Hypertens (Greenwich). 2021 Jul;23(7):1291-1299. doi: 10.1111/jch.14304. Epub 2021 Jun 16.
4
Multiple comparisons in carcinogenesis study with right-censored survival data.
Stat Med. 2000 Feb 15;19(3):353-67. doi: 10.1002/(sici)1097-0258(20000215)19:3<353::aid-sim333>3.0.co;2-b.
5
Evaluation of survival data and two new rank order statistics arising in its consideration.生存数据的评估以及在考虑过程中出现的两个新的排序统计量。
Cancer Chemother Rep. 1966 Mar;50(3):163-70.